Alternative Explanation Conditions Often Delay Lung Cancer Diagnosis
By Lori Solomon HealthDay Reporter
WEDNESDAY, Sept. 11, 2024 -- Conditions offering alternative explanations for lung cancer symptoms are associated with increased diagnostic intervals, according to a study published online Aug. 23 in the British Journal of Cancer.
Imogen Rogers, from Brighton and Sussex Medical School in the United Kingdom, and colleagues examined the diagnostic interval from time of first presentation in primary care with a relevant sign/symptom to diagnosis date for 11,870 people with lung cancer diagnoses and associations between the diagnostic interval and 10 “competing demand” comorbidities and four “alternative explanation” conditions. The "competing demand" comorbidities included coronary heart disease, depression/anxiety, heart failure, hypertension, chronic kidney disease, osteoporosis, dementia, serious mental illness, epilepsy, and diabetes. The "alternative explanation" conditions were chronic obstructive pulmonary disease, asthma, chronic fatigue syndrome, and receiving a prescription for an angiotensin-converting enzyme inhibitor.
The researchers found that the diagnostic interval was longer for patients with “alternative explanation” conditions, by 31 and 74 days in patients with one and two or more conditions, respectively, compared with those with none. In an adjusted analysis, the number of “competing demand” conditions did not remain significantly associated with the diagnostic interval.
"This research underscores the need for heightened vigilance in patients with chronic respiratory conditions," Rogers said in a statement. "Recognizing that these conditions can mask the symptoms of lung cancer is crucial in ensuring timely diagnosis and treatment."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Molgramostim Beneficial in Autoimmune Pulmonary Alveolar Proteinosis
THURSDAY, Aug. 21, 2025 -- In adults with autoimmune pulmonary alveolar proteinosis (aPAP), once-daily inhaled molgramostim, a recombinant human granulocyte-macrophage...
440 Deaths in Los Angeles County Reported Due to January 2025 Wildfires
TUESDAY, Aug. 12, 2025 -- An estimated 440 deaths from Jan. 5 to Feb. 1, 2025, in Los Angeles County were attributable to the Los Angeles wildfires, according to a research letter...
Increased Intake of Ultraprocessed Food Raises Lung Cancer Risk
THURSDAY, July 31, 2025 -- Higher consumption of ultraprocessed foods (UPF) is associated with increased risk of lung cancer, according to a study published online July 29 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.